# Immunogenicity of MF59-adjuvanted Versus High-dose Influenza Vaccine in People With HIV: a Randomized Clinical Trial

> **NCT07644546** · NA · NOT_YET_RECRUITING · sponsor: **National Taiwan University Hospital** · enrollment: 350 (estimated)

## Conditions studied

- HIV

## Interventions

- **BIOLOGICAL:** IM

## Key facts

- **NCT ID:** NCT07644546
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09-01
- **Primary completion:** 2027-02-28
- **Final completion:** 2028-12-31
- **Target enrollment:** 350 (ESTIMATED)
- **Last updated:** 2026-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07644546

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07644546, "Immunogenicity of MF59-adjuvanted Versus High-dose Influenza Vaccine in People With HIV: a Randomized Clinical Trial". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07644546. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*